Denis Naughten
Question:1791. Deputy Denis Naughten asked the Minister for Health when adjuvant abemaciclib will be approved to reduce the risk of breast cancer for patients; and if he will make a statement on the matter. [1861/24]
View answerWednesday, 17 January 2024
Questions (1791)
Written answers
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.